“…Early in the pandemic, it was recognized that the physiological behavior of COVID-19 lung disease is often distinct from that typically encountered in ARDS/DAD ( Gattinoni et al, 2020 ). To the trained eye of a pulmonologist, the thoracic imaging appearance of early COVID-19 lung disease is less reminiscent of corticosteroid-resistant ARDS/DAD and more reminiscent of corticosteroid-sensitive substrates such as organizing pneumonia (OP), acute eosinophilic pneumonia (AEP), and vasculitis ( Hani et al, 2020 , Nemec et al, 2013 ). Although both influenza and coronavirus infect respiratory epithelial cells, there is histopathological evidence from the 2003 severe acute respiratory syndrome coronavirus (SARS-CoV) epidemic to suggest that the former has a more dramatic propensity than the latter for catastrophic lung injury in the form of DAD ( Ng et al, 2006 ).…”